David Beyer Overview
- Investor Type
- Angel
- Status
- Active
- Professionals
- 1
- Investments
- 39
- Portfolio
- 19
- Exits
- 21
David Beyer General Information
Description
Mr. David Beyer serves as Partner at Amplify Partners. He joined Amplify in 2013. He served as the Chief Executive Officer of Chart.io. He co-founded J2DR and also served as its Chief Executive Officer. Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He was subsequently part of the founding team at Patients Know Best, one of the world's leading cloud-based personal health record companies. He is an Angel Investor.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
- San Francisco, CA
- United States
+1 (240) 000-0000
David Beyer Investments (39)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Campaign | 11-Jan-2018 | Later Stage VC | 000.00 | Home Furnishings | Generating Revenue | 00000 00000 |
| 000000000 | 08-Apr-2016 | 00000 00000 | 000 | Social/Platform Software | Generating Revenue | 00000 00000 |
| 00000000 | 30-Sep-2015 | 00000 00000 | 0000 | Business/Productivity Software | Generating Revenue | 00000 00000 |
| 000000 (0000000000 | 18-Sep-2015 | 00000 00000 | 000.00 | Automotive | Generating Revenue | 00000 00000 |
| 0000 0000 (0000000 | 01-May-2015 | 0000 00000 | 00.00 | Financial Software | Generating Revenue | 00000 00000 |
| 0000000 0000000000 | 20-Mar-2015 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 00000 |
| 00000000 | 25-Feb-2015 | 00000 00000 | 000 | Software Development Applications | Generating Revenue | 00000 00000 |
| 0000 00 | 03-Feb-2015 | 0000 00000 | 000 | Operating Systems Software | Generating Revenue | 00000 00000 |
| Zephyrus Biosciences | 10-Sep-2014 | Seed Round | 00.00 | Biotechnology | Startup | 00000 00000 |
| Ginkgo Bioworks | 02-Sep-2014 | Later Stage VC | Other Healthcare Technology Systems | Generating Revenue | 00000 00000 |
David Beyer Exits (21)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Zymergen | 22-Apr-2021 | IPO | 00000 |
| 0000000 | 26-Feb-2021 | 000000000000000000 | 000.00 |
| 000000000 | 09-Jan-2020 | 000000000000000000 | 0000 |
| 000000000 | 20-Aug-2019 | 000000000000000000 | |
| 000 00000 | 28-Aug-2018 | 000000000000000000 | 0000 |
| 000000000 | 17-Aug-2017 | 000000000000000000 | |
| 000000 | 30-May-2017 | 000000000000000000 | 000 |
| 0000&0000000 | 30-Mar-2017 | 000000000000000000 | 0000 |
| Cruise (California) | 16-May-2016 | Merger/Acquisition | 00000 |
| Genome Compiler | 07-Apr-2016 | Merger/Acquisition | 00.00 |
David Beyer Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialDavid Beyer Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| David Beyer | Angel Investor | 00 | San Francisco, CA |
David Beyer Co-Investors (15)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Blumberg Capital | 1 | 0 |
|
|
|
| Bodley Group | 0 | 0 |
|
|
|
| Kima Ventures | 0 | 0 |
|
|
|
| Ludlow Ventures | 0 | 0 |
|
|
|
| Valor Equity Partners | 0 | 0 |
|
|